Yes. The majority of new GLP-1 prescriptions in the US are now written by telehealth providers rather than in-person physicians, and it is entirely legal. But "without a doctor visit" does not mean "without medical oversight." A legitimate telehealth prescription still involves a licensed clinician reviewing your history and screening for the conditions that make these drugs unsafe. The convenience is real; the medical evaluation does not disappear, it just happens differently. Here is exactly how the process works, what a responsible provider checks, and the red flags that separate real care from a slick checkout page.
How telehealth prescribing works
Telehealth platforms that offer GLP-1 medications use licensed prescribers (physicians, nurse practitioners, or physician assistants) who review your information either asynchronously or over video or chat. The process typically looks like this:
- You complete a detailed medical intake covering your weight, BMI, health history, current medications, allergies, and relevant conditions.
- A licensed clinician reviews your intake, and on many platforms follows up by video or secure messaging.
- If you meet the clinical criteria and have no contraindications, a prescription is issued.
- The medication is sent to a pharmacy or shipped to your door.
No in-person appointment is required. The clinical evaluation happens through the questionnaire and, on many platforms, a video or messaging consultation. For the practical mechanics of ordering, see how to get GLP-1 online.
Is this actually legal?
It is. Telehealth prescribing of GLP-1 medications is legal across the US, and rules that were loosened during the pandemic made remote prescribing of non-controlled drugs routine. GLP-1 medications are not controlled substances, which is part of why they can be prescribed this way. What varies is not legality but the quality of the clinical oversight behind the prescription, and that is where your attention belongs.
What the clinician is actually checking
This matters because GLP-1 medications have real contraindications. A responsible telehealth provider screens for a personal or family history of medullary thyroid cancer or MEN 2 syndrome, a history of pancreatitis, severe gastrointestinal disease such as gastroparesis, pregnancy or plans to become pregnant, and known hypersensitivity to the drug. They are also confirming that your BMI and health profile meet the prescribing criteria, generally a BMI of 30 or above, or 27 and above with a weight-related condition. A provider that does not ask about any of this is not practicing safely. See who qualifies for a GLP-1 prescription and the checklist before starting.
What a legitimate async evaluation looks like
"Asynchronous" care sometimes gets a bad reputation, but done properly it is a real clinical evaluation, not a rubber stamp. A sound async process gathers a thorough history, flags anything that needs a follow-up question, gives the clinician a way to request more information or a video call before prescribing, and produces a prescription tied to a named, licensed provider you could look up. The difference between good and bad async care is whether a clinician can and will say no or ask for more, or whether approval is effectively automatic once payment clears.
Brand vs compounded through telehealth
Most telehealth GLP-1 providers offer compounded semaglutide or tirzepatide rather than brand-name Wegovy or Zepbound. Compounded versions are significantly cheaper but are not FDA-approved products: they are made by compounding pharmacies and lack the brand's approval, standardization, and regulatory oversight. Some platforms offer brand-name drugs, which cost more but go through the standard pharmacy supply chain. The trade-offs are laid out in compounded GLP-1 online and compounded semaglutide vs Wegovy, and the cost picture in what GLP-1 medications actually cost.
What happens after you are approved
Getting the prescription is the start, not the finish. On a well-run platform the weeks that follow look roughly like this: your first shipment arrives with the lowest starting dose, because GLP-1 medications are titrated up slowly to limit side effects. You inject once a week and, on most platforms, can message a clinician if nausea or other symptoms flare. After a few weeks at the starting dose, the provider steps you up to the next dose on a schedule, pausing or slowing if you are struggling. Periodic check-ins track your progress and tolerability. If your provider ships a full high dose from day one, or steps you up with no check-in, that is a sign the clinical oversight is thin. For what the early weeks feel like, see what to expect in your first month and the GLP-1 side-effects timeline.
What telehealth cannot replace
- Ongoing lab monitoring. Some situations warrant periodic bloodwork, which telehealth can order but not perform.
- Complex medical histories. If you have multiple conditions or take several medications, a specialist or primary care physician who knows your full history is more appropriate than an intake form.
- Physical examination. Telehealth cannot examine you, and some presentations warrant an in-person evaluation first.
Red flags in telehealth GLP-1 providers
- No clinical intake, just a checkout flow.
- No identifiable licensed prescriber on staff.
- No screening for contraindications.
- No way to reach clinical support after you start.
- Automatic refills with no check-ins.
If you see these, walk away. A fuller vetting checklist is in how to choose a telehealth provider, and vetted comparisons in the best telehealth GLP-1 providers and best online GLP-1 programs.
When you should still see someone in person
Telehealth is a good fit for most healthy adults who qualify on BMI and have a straightforward history, but some situations are better handled face to face, at least to start. Consider in-person care if you have a complex medical history or take several interacting medications, if you have a history of pancreatitis, gallbladder disease, or significant gastrointestinal problems, if you are managing diabetes alongside other conditions, or if you are pregnant, breastfeeding, or planning a pregnancy. None of these automatically rule out a GLP-1, but they are exactly the cases where a clinician who can examine you and knows your full record adds real value. Starting in person does not lock you out of telehealth later, and many people do a hybrid: an initial workup with their own doctor, then telehealth for convenient ongoing refills.
The legitimate path
A legitimate telehealth prescription for a GLP-1 medication is a real, valid prescription from a real licensed clinician. The convenience is real, and so are the savings over in-person care. The requirement for actual medical evaluation does not vanish; it simply happens through an intake and a remote consultation instead of a waiting room. Choose a provider that makes the clinician, the screening, and the pricing all visible, and you get the convenience without giving up the safety.
Frequently asked questions
Do I need to have tried other weight-loss methods first?
Not universally, though some insurers require it for coverage (step therapy). A telehealth provider prescribing on a cash basis generally screens on BMI and health history rather than prior diet attempts, but a good one still asks about your history.
Will I ever need to be seen in person?
Often not, but a responsible provider will refer you for in-person care if your history is complex, if labs raise a concern, or if a symptom needs a physical exam. That willingness to refer is a sign of a good provider, not a limitation.
Is a telehealth prescription the same as one from my regular doctor?
Legally, yes: it is a valid prescription from a licensed clinician. The difference is continuity. Your own physician knows your full history, so if you have complex needs, looping them in is wise even if you start through telehealth.
This is educational content, not medical advice. Telehealth prescribing is legal and increasingly common, but the quality of clinical oversight varies significantly across providers. Choose one with identifiable, licensed prescribers and a real intake process.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Every claim is checked against peer-reviewed research through our review process and fact-checking policy.
Frequently Asked Questions
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, but they are FDA-approved for different indications. Ozempic (up to 2mg) is approved for type 2 diabetes management and cardiovascular risk reduction. Wegovy (up to 2.4mg) is approved for chronic weight management. The distinction directly affects insurance coverage, maximum dose, and prescribing eligibility โ and the two are not interchangeable through most pharmacies.
Do I need a prescription for semaglutide or tirzepatide?
Yes. Semaglutide and tirzepatide are prescription-only medications in the United States and most countries. They require evaluation and a prescription from a licensed healthcare provider. Compounded versions have been available through telehealth platforms, but these are not FDA-approved and carry different regulatory and quality considerations.
How long does it take to see results on GLP-1 medications?
Appetite changes are typically noticed in weeks 1-2. Meaningful weight loss (5-10% of body weight) generally occurs by weeks 12-20. Clinical trial results are measured at 68-72 weeks. The dose escalation schedule means the first 16-20 weeks are primarily about building tolerance, not maximum efficacy. Individual response varies significantly.
What happens when you stop taking a GLP-1 medication?
Most people regain a significant portion of lost weight within 12 months of stopping. Discontinuation studies show that the compensatory hunger and metabolic changes that GLP-1 medications suppress tend to return when the medication is withdrawn. Many clinicians now frame these as long-term treatments โ similar to antihypertensives โ rather than short-term interventions.
Continue learning
Where to read next
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.

